Ionis Pharmaceuticals Inc (IONS)
41.59
-0.25
(-0.60%)
USD |
NASDAQ |
Apr 26, 16:00
41.58
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Financing (Quarterly): 40.72M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.72M |
| September 30, 2023 | -32.27M |
| June 30, 2023 | 143.54M |
| March 31, 2023 | 492.09M |
| December 31, 2022 | -51.02M |
| September 30, 2022 | 1.834M |
| June 30, 2022 | 1.215M |
| March 31, 2022 | -7.325M |
| December 31, 2021 | -62.49M |
| September 30, 2021 | 1.458M |
| June 30, 2021 | 314.54M |
| March 31, 2021 | -7.577M |
| December 31, 2020 | -521.48M |
| September 30, 2020 | 10.94M |
| June 30, 2020 | 8.435M |
| March 31, 2020 | -94.50M |
| December 31, 2019 | 19.22M |
| September 30, 2019 | -13.17M |
| June 30, 2019 | 34.51M |
| March 31, 2019 | 59.46M |
| December 31, 2018 | 9.646M |
| September 30, 2018 | 8.076M |
| June 30, 2018 | 452.92M |
| March 31, 2018 | 5.224M |
| December 31, 2017 | 4.257M |
| Date | Value |
|---|---|
| September 30, 2017 | 147.57M |
| June 30, 2017 | 1.712M |
| March 31, 2017 | 75.55M |
| December 31, 2016 | 6.448M |
| September 30, 2016 | 4.543M |
| June 30, 2016 | -0.476M |
| March 31, 2016 | 0.879M |
| December 31, 2015 | 11.71M |
| September 30, 2015 | 0.167M |
| June 30, 2015 | 1.319M |
| March 31, 2015 | 11.53M |
| December 31, 2014 | 49.88M |
| September 30, 2014 | 1.682M |
| June 30, 2014 | -1.288M |
| March 31, 2014 | 9.312M |
| December 31, 2013 | 3.327M |
| September 30, 2013 | 17.36M |
| June 30, 2013 | 197.99M |
| March 31, 2013 | 9.05M |
| December 31, 2012 | -1.151M |
| September 30, 2012 | 34.40M |
| June 30, 2012 | 7.737M |
| March 31, 2012 | -1.853M |
| December 31, 2011 | 0.585M |
| September 30, 2011 | -0.888M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-521.48M
Minimum
Dec 2020
492.09M
Maximum
Mar 2023
14.67M
Average
1.458M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 479.92M |
| Viking Therapeutics Inc | 606.04M |
| Alnylam Pharmaceuticals Inc | 39.23M |
| Akero Therapeutics Inc | 0.502M |
| 89bio Inc | 162.17M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.86M |
| Cash from Investing (Quarterly) | -26.71M |
| Free Cash Flow | -335.52M |
| Free Cash Flow Per Share (Quarterly) | 0.229 |
| Free Cash Flow to Equity (Quarterly) | 29.52M |
| Free Cash Flow to Firm (Quarterly) | 108.04M |
| Free Cash Flow Yield | -5.63% |